OrthoIndy, OrthoIndy Hospital name new CEO
The new hire replaces John Ryan, who last month was named Indiana University Health’s new chief strategy officer.
Health Care Businesses
-
Q&A: OrthoIndy’s John Ryan talks about staying independent in a consolidating health care industry
The economics are daunting: Rising costs and flat reimbursements mean private groups must work harder to stay independent.
Read More -
Elanco’s dermatology treatment for itchy dogs gets FDA approval
Zenrelia is one of several drugs Elanco has in its pipeline that it predicts could reach blockbuster status, which in animal health means more than $100 million in annual sales.
Read More -
Surgeons from across the U.S. come to Indiana Spine Group to learn the latest techniques
The Carmel medical group is gaining a reputation as a training and education center. It holds courses for high school and college students in anatomy as well as surgeons going out on their own after residencies and fellowships.
Read More -
IBJ Podcast: Sam Schmidt on his paralysis journey, basing national clinic expansion in Indy
In this week’s edition of the podcast, Schmidt shares his story of recovery from a near fatal injury and how he uses it to help inspire others with mobility issues.
Read More
Articles
Health insurance sticker shock begins as shutdown battle over subsidies rages
Lawmakers face greater pressure to act as Americans who buy insurance through the Affordable Care Act are seeing, or about to see, the consequences of enhanced subsidies expiring at the end of the year.
Community Health Network names physician, strategic growth leader as new CEO
He succeeds longtime leader Bryan Mills, who announced his retirement earlier this year after more than 40 years working for Community.
Mounjaro price hike fuels UK pharmacy battle to retain customers
Eli Lilly and Co. announced this month it would raise the weight-loss treatment’s price by as much as 170%, presenting pharmacies with a dilemma about how much they would pass on to patients.
Firm tied to Trump Jr. debuts direct sales product for pharma companies
Eli Lilly and Co. has already launched LillyDirect service, which CEO David Ricks says jibes with the administration’s demand for direct sales. Lilly is working with Truepill and Amazon.com Inc.’s pharmacy unit on its platform.
Lilly hosts Reddit ‘Ask Me Anything’ Q&A on blockbuster weight-loss drug Zepbound
Questions included whether the Indianapolis-based drugmaker is working to improve insurance coverage for the drug and highlighted users’ concerns about comparisons with Novo Nordisk’s Wegovy.
Construction on $4.3B downtown IU Health hospital complex nears halfway mark
The 44-acre campus will span approximately eight square blocks in downtown Indianapolis, replacing Methodist and University hospitals.
Preserving young patient’s hair prompts IU surgeons’ invention
The desire to preserve a girl’s flowing hair during brain surgery led to the development of a comb-like device that could help cranial surgery patients avoid having their heads shaved.
Carmel-based health tech firm to delist from Nasdaq
Syra Health Corp. plans to offer stock on the over-the-counter market after the company failed to meet Nasdaq Stock Market’s price requirements for its shares.
Study co-authored by IU researcher finds generic drugs made in India have more severe adverse events
The results showed that the number of severe adverse events for patients was 54.3% higher than that of drugs made in emerging economies.
Dental office agrees to pay state $350K after data breach, privacy investigation
Under a proposed settlement agreement, Westend Dental would not admit to violating any laws.
Ambulatory surgical center offers ‘fairly-priced’ alternative
Wellbridge Surgical is also selling price transparency, with an extensive website that lists prices for more than 250 procedures, ranging from an ear tube removal ($2,610) to a total knee replacement ($23,000).
UK regulator approves Lilly’s new Alzheimer’s drug but government won’t pay for it
Britian’s National Institute for Health and Care Excellence said more evidence was needed to prove Kisunla’s worth. Lilly says a year’s worth of treatment is $32,000.
Former IndyCar driver Sam Schmidt opens facility Tuesday to help people with paralysis
After a racing accident in 2000 left Schmidt a quadriplegic, he created a not-for-profit called Conquer Paralysis Now, which has invested $21.4 million to convert the former Five Seasons Sports Club into a state-of-the-art rehab center.
Northwind Pharma planning $10.5M expansion, 205 new hires
The Indianapolis company, located in the former St. Bernadette Catholic Church on the near-east side, plans to make the hires by the end of 2025.
Anthem Inc. to change corporate name to Elevance Health
The Indianapolis-based health insurer said the name change will better reflect its mission of “elevating whole health and advancing health beyond healthcare.”
Two former Anthem employees sue company, claim high quotas resulted in unpaid overtime
Two former employees of Anthem Inc. claim the Indianapolis-based health insurer set work quotas so high that it was impossible to meet them in a 40-hour week, forcing them to work unpaid overtime. Anthem declined to comment.
Omicron may sideline Lilly, Regeneron antibody drugs against COVID-19
The companies say they can quickly develop new omicron-targeting antibodies, but those aren’t expected to launch for at least several months.
Health care firm that runs clinics for employers is expanding nationwide
Marathon Health, which splits its headquarters between Indianapolis and suburban Burlington, Vermont, operates primary-care clinics for employers in 42 states.
2021 Indiana 100: Taltz leader sees more potential for blockbuster Lilly drug
Mathilde Merlet oversees one of Eli Lilly and Co.’s fastest-growing products, a medicine called Taltz that treats a variety of dermatology and rheumatology disorders.